Effects of serotonin and metergoline on 125[I]-iodocyanopindolol binding parameters to beta-adrenergic receptors in rat brain

European Neuropsychopharmacology

Volumn 8, Issue 2, 1998, Pages 131-140

  Gurguis, George N M ^a   Turkka, Jukka ^b   Linnoila, Markku ^c  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

5 HT(1B) receptors; Antidepressants; Beta adrenergic receptors ( AR); Iodocyanopindolol; Metergoline; Serotonin

Indexed keywords

ASCORBIC ACID; BETA ADRENERGIC RECEPTOR; CYANOPINDOLOL I 125; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; GUANYLYLIMIDODIPHOSPHATE; ISOPRENALINE; METERGOLINE; SEROTONIN; SEROTONIN 1B RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DISSOCIATION CONSTANT; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; BRAIN CHEMISTRY; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; GUANYLYL IMIDODIPHOSPHATE; HIPPOCAMPUS; IODOCYANOPINDOLOL; MALE; METERGOLINE; PINDOLOL; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0031921533     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00059-X     Document Type: Article

References (60)

1. Banerjee S.P., Kung L.S., Riggi S.J., Chanda S.K. Development of β-adrenergic receptor subsensitivity by antidepressants. Nature. 268:1977;455-456.
2. 1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur. J. Pharmacol. 151:1988;189-196.
3. Burger, E., Lefkowitz, R.J., 1984. Beta adrenergic receptors. In: Marangos, P.J., Campbell, I.C., Cohen, R.M. (Eds.) Brain Receptor Methodologies. Part A, Academic Press, New York, pp. 229-253.
4. 1B/D receptor ligands. Pharmacol. Ther. 62:1994;385-405.
5. Davies A.O., Lefkowitz R.J. Agonist-promoted high affinity state of the beta-adrenergic receptor in human neurophils: modulation by corticosteroids. J. Clin. Endocrinol. Metab. 53:1981;703-708.
6. Davies A.O., Lefkowitz R.J. Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating humane polymorphonuclear leukocytes and mononuclear leukocytes. J. Clin. Endocrinol. Metab. 51:1980;599-605.
7. DeLean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled P-adrenergic receptor. J. Biol. Chem. 255:1980;7108-7117.
8. Duncan G.E., Knap D.J., Little K.Y., Breese G.R. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor downregulation in rat brain. J. Pharmacol. Exp. Ther. 271:1994;1699-1704.
9. Edwards E., Whitaker-Azmitia P.M. Selective P-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus. Neuropharmacol. 26:1987;93-96.
10. 1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;1-7.
11. Feuerstein T.J., Lupp A., Hertting G. The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration. Neurochem. Res. 26:1987;1071-1987.
12. Gillespie D.D., Manier H.D., Sulser F. Characterization of the inducible serotonin-sensitive dihydroalprenolol binding sites with low affinity for isoproterenol. Neuropharmacol. 2:1989;265-271.
13. Gillespie D.D., Manier H.D., Sanders-Bush E., Sulser F. The serotonin/norephinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation. J. Pharmacol. Exp. Ther. 244:1988;154-159.
14. Gillespie D.D., Manier D.H., Sulser F. Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down-regulation of beta adrenergic receptors. Comm. Psychopharmacol. 3:1979;191-195.
15. Gilman, A.G., 1990. Regulation of adenylyl cyclase by G proteins. In: Nichizuka, Y. (Ed.) The Biology and Medicine of Signal Transduction. Raven Press, New York, pp. 51-57.
16. Gilman A.G. G proteins and regulation of adenylyl cyclase. J. Am. Med. Assoc. 262:1989;1819-1825.
17. Gothert M., Huth H. Alpha-adrenoreceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 313:1980;21-26.
18. Graeser, D., Neubig, R.R., 1992. Methods for the study of receptor/G-protein interactions. In: Milligan, G. (Ed.), Signal Transduction: A Practical Approach, New York, Oxford University Press, pp. 1-30.
19. Guan X.M., Peroutka S.J., Kobilka B.K. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic antagonists to 5-hydroxytryptamine 1A receptors. Mol. Pharmacol. 41:1992;695-698.
20. Hensler J.G., Ordway G.A., Gambarana C., Areso P., Frazer A. Serotonergic neurons do not influence the regulation of beta adrenoreceptors induced by either desipramine or isoproterenol. J. Pharmacol. Exp. Ther. 256:1991;656-664.
21. 125I]iodocyanopindolol. Eur. J. Pharmacol. 118:1985;1-12.
22. 3H] Ketanserine. Eur. J. Pharmacol. 118:1985;13-23.
23. Kellar K.J., Bergstrom D.A. Electroconvulsive shock: Effects on biochemical correlates of neurotransmitter receptors in rat brain. Neuropharmacol. 22:1983;401-406.
24. Kent R.S., DeLean A., Lefkowitz R.J. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17:1980;14-19.
25. 2-adrenoceptors at the serotonergic axons of rabbit brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;324-331.
26. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Manier D.H., Gillespie D.D., Sulser F. Dual aminergic regulation of central beta adrenoreceptors: effect of 'atypical' antidepressants and 5-hydroxytryptophan. Neuropsychopharmacol. 2:1989;89-95.
28. Manier D.H., Gillespie D.D., Sanders-Bush E., Sulser F. The serotonin/noradrenaline-link in brain I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoreceptors and its alteration by desipramine. Naunyn-Schmiedeberg's Arch. Pharmacol. 335:1987;109-114.
29. Manier D.H., Gillespie D.D., Sulser F. 5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and despramine-induced down-regulation of cortical beta adrenoceptors: a re-evaluation. Biochem. Pharmacol. 6:1987;3308-3310.
30. 2-adrenoreceptor subtypes. Naunyn-Schemiedeberg's Arch. Pharmacol. 345:1992;410-416.
31. 2-adrenoreceptors located on serotonergic nerve terminals. Naunyn-Schmiedeberg's Arch. Pharmacol. 320:1982;272-274.
32. Middlemiss D.N. Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonist. Eur. J. Pharmacol. 120:1986;51-56.
33. 1B receptors. Ann. New York Acad. Sci. 600:1990;132-147.
34. Morin D., Sapena R., Zini R., Tillement J.-P. Serotonin enhances the β-adrenoreceptor response in rat brain frontal cortical slices. Eur. J. Pharmacol. 225:1992;273-274.
35. Munson R.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107:1983;220-239.
36. Murphy T.J., Bylund D.B. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J. Pharmacol. Exp. Ther. 249:1989;535-543.
37. 1B receptors in the brain of the rat. J. Pharmacol. Exp. Ther. 244:1988;144-153.
38. 125I-iodocyanopindolol to Beta-1 adrenoreceptors in the amygdala of rat after antidepressant treatments. J. Pharmacol. Exp. Ther. 257:1991;681-690.
39. 2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. J. Pharmacol. Exp. Ther. 246:1988;956-962.
40. Raiteri M., Maura G., Floghera S., Cavazzani P., Andriolo G.C., Schlicker E., Schalnus R., Gothert M. Modulation of 5-hydroxytryptamine release by presynaptic inhibitory Alpha2-adrenoreceptors in the human cereberal cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;508-512.
41. Reinhard J.F., Roth R.H. Noradrenergic modulation of serotonin synthesis and metabolism. I. inhibition by clonidine in vivo. J. Pharmacol. Exp. Ther. 221:1982;541-546.
42. Riva M.A., Creese I. Reevaluation of the regulation of β-adrenergic receptor binding by desipramine treatment. Mol. Pharmacol. 36:1989;211-218.
43. 3H] dihydroalprenolol. Mol. Pharmacol. 36:1989;201-210.
44. Ross E.M. Signal sorting and amplification through G protein-coupled receptors. Neuron. 3:1989;141-152.
45. Saudou F., Hen R. 5-hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv. Pharmacol. 30:1994;327-380.
46. 1D receptors mediating inhibition of adenylate cyclase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;285-292.
47. 3H] dihydroalprenolol binding in rat brain. Mol. Pharmacol. 36:1989;903-911.
48. Sulser F., Gillespie D.D., Mishra R., Manier D.H. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Ann. New York Acad. Sci. 430:1984;91-101.
49. Sulser F. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders. J. Clin. Psychiatry. 48(3 suppl):1987;1218.
50. 2-autoreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;25-33.
51. 125I-Iodocyanopindolol to β-adrenergic receptors in rat cerebral cortical membranes. I. assessment by the use of agonists. Chem. Pharm. Bull. 35:1987;2966-2972.
52. 3H-cgp12177. Jpn. J. Pharmacol. 50:1989;93-100.
53. 1B-serotonergic receptors in rat brain determined by the displacement and Schatchard analysis. J. Pharmacobiol. Dyn. 12:1989;509-516.
54. 125I-iodocyanopindolol binding to P-adrenergic and serotonin-1B receptors of rat brain: selectivity of P-adrenergic agents. Jpn. J. Pharmacol. 52:1990;195-200.
55. Turkka J., Gurguis G., Karanian J., Potter W.Z., Linnoila M. Effects of chronic exposure to ethanol alone and in combination with desipramine on β-adrenoceptors of rat brain. Eur. J. Pharmacol. 177:1990;171-179.
56. H for β-receptors in rat hippocampus. Eur. J. Pharmacol. 167:1989;87-93.
57. Valverius P., Hoffman P.L., Tabakoff B. Effects of ethanol on mouse cereberal cortical beta-adrenergic receptors. Mol. Pharmacol. 32:1987;217-222.
58. Vetulani J., Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in the limbic forebrain. Nature. 257:1975;494-496.
59. Vetulani J., Stawartz R.J., Dingell R.V., Sulser F. A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP generating system in the rat limbic forebrain. Naunyn-Schmiedeberg's Arch. Pharmacol. 293:1976;109-114.
60. 2-adrenoreceptors in the rat hippocampus after long-term desipramine treatment. Eur. J. Pharmacol. 294:1995;565-570.